778 F.2d 547 (10th Cir. 1985), 83-1214, Robert A. Wachsler, Inc. v. Florafax Intern., Inc.

Docket Nº:83-1214.
Citation:778 F.2d 547
Party Name:ROBERT A. WACHSLER, INC., a Connecticut corporation, Plaintiff-Appellee, v. FLORAFAX INTERNATIONAL, INC., a Delaware corporation, Defendant-Appellant.
Case Date:November 26, 1985
Court:United States Courts of Appeals, Court of Appeals for the Tenth Circuit

Page 547

778 F.2d 547 (10th Cir. 1985)

ROBERT A. WACHSLER, INC., a Connecticut corporation,



FLORAFAX INTERNATIONAL, INC., a Delaware corporation,


No. 83-1214.

United States Court of Appeals, Tenth Circuit

November 26, 1985

Page 548

Ira L. Edwards, Jr., Houston & Klein, Inc., Tulsa, Okl. (Drew R. Heard and John T. Helm of Shank, Irwin & Conant, Dallas, Tex., on brief), for defendant-appellant.

Joel L. Wohlgemuth (Janet Spaulding also of Prichard, Norman & Wohlgemuth, with him on brief), Tulsa, Okl., for plaintiff-appellee.

Before BARRETT and LOGAN, Circuit Judges, and SAFFELS, District Judge. [*]

LOGAN, Circuit Judge.

In this diversity action defendant Florafax International, Inc. appeals a $240,000 judgment rendered against it in a jury trial for breach of contract brought by plaintiff Robert A. Wachsler, Inc. (RAW). Florafax is a publicly held Delaware corporation with its principal place of business in Oklahoma. RAW is a closely held Connecticut corporation with its principal place of business in Connecticut.

The issues on appeal are (1) whether Oklahoma or Delaware corporate law governs this suit; (2) concluding, as we do, that Delaware law controls, whether Del.Code Ann. tit. 8, Sec. 144 is the exclusive means of ratifying interested director contracts; and (3) if not, whether the jury verdict that Florafax did ratify the contract with RAW may be upheld under the standards that would then properly apply.

Robert A. Wachsler is a marketing consultant who served on the board of directors of Florafax. He is president of RAW and, together with his wife, owns all of RAW's stock. RAW's principal business is marketing Wachsler's personal consulting services. For a short time before Wachsler and Michael Lupo, president and chief executive officer of Florafax, signed the contract in question, RAW had been receiving $3,500 per month from Florafax for serving as a marketing consultant. At this time, other Florafax directors also were receiving fees from the corporation under agreements that did not have formal advance approval of the board of directors.

In June 1980, Wachsler brought a draft of a proposed agreement between Florafax and RAW to a Florafax marketing meeting. The contract provided that RAW would supply consulting services to Florafax for five years for a $60,000 annual fee. Wachsler discussed the contract with Lupo and Richard Hughes, Florafax's chairman. Lupo signed the contract on behalf of Florafax some time before June 26, although it was never presented to or approved by the board of directors. On that date apparently all the board of directors members together owned or controlled no more than 36.8% of Florafax's outstanding voting stock. 1

Page 549

On June 26 Hughes announced to the Florafax board of directors by way of a conference telephone call that he had sold his Florafax stock to Joseph Hale, who on that day became the new chairman of the board and chief executive officer of Florafax. Lupo remained as Florafax's president and chief operating officer. Hale soon learned of the consulting agreement with RAW, and at a meeting with Lupo and Wachsler on July 22, he informed Wachsler that Florafax would not honor the contract. Lupo then sent RAW a letter dated August 22, 1980, in which he referred to the minutes of an April 9 board of directors meeting that purported to preclude contracts made without prior board approval. 2

Wachsler resigned from the Florafax board on November 4. The remaining directors, with the exception of Lupo, resigned shortly thereafter. On November 24, 1980, a new board composed of Hale, Lupo, and two new directors formally disavowed the contract with RAW. Florafax never paid any fees to RAW under the contract.

Soon after Wachsler's resignation from the board, RAW brought suit for breach of contract. The complaint alleged that Florafax had ratified the contract when its president Lupo asked RAW in June 1980 to provide a major marketing analysis of the method by which Florafax could increase the sale of silk flowers to gift shops and then utilized this analysis in marketing Florafax products. Florafax denied ratification and claimed to have returned all copies of the marketing analysis without ever using it. Nevertheless there was some evidence at trial from which the jury could have found that Florafax in fact used some of RAW's marketing ideas.


The parties initially contested the issue of whether Oklahoma or Delaware law is applicable to this suit. At trial, however, neither party objected when the district court applied Oklahoma law, apparently because the relevant statutes of the states are substantively identical. 3 We are convinced that Delaware law should be applied to determine the questions at issue here, and we rely primarily on the relevant statute and cases from that state. Nonetheless, we have examined the Oklahoma authorities cited, and, although that state's law is not as fully developed, we are convinced that the Oklahoma and Delaware supreme courts would arrive at the same conclusion. 4

Sitting as a federal court in a diversity case, we must apply the substantive law that an Oklahoma state court would apply, including that state's choice of law rules. Klaxon Co. v. Slentor Electric Manufacturing Co., 313 U.S. 487, 496, 61 S.Ct. 1020, 1021, 85 L.Ed. 1477 (1941). Although there is no recent Oklahoma Supreme Court decision directly on point, we are convinced that an Oklahoma court would

Page 550

apply the choice of law...

To continue reading